argenx SE (1AE.F)
Develops antibody drugs to treat autoimmune diseases like myasthenia gravis and immune thrombocytopenia.
765.60-0.04%Healthcare
StockGlow Score
Bullish
BearishBullish
1 year ago+32.0%
The outlook
Argenx SE trades at 765.6, sitting well above both its 50- and 200-day moving averages and roughly 79% of the way through its 52-week range. The stock carries a trailing P/E of 33.1 and shows a bullish technical setup, though analyst coverage appears sparse. Today's price movement was essentially flat.
What’s behind the score
Price trendAbove its 50- & 200-day averages
52-week range79% of the way from its 52-week low to high
Market cap
$47.61B
52-wk high
833.00
52-wk low
514.40
50-day avg
759.28
200-day avg
713.12
Trailing P/E
33.1